T1	Participants 59 70	adolescents
T2	Participants 160 244	hypertensive adolescents requiring pharmacologic therapy for blood pressure control.
T3	Participants 245 341	Twenty-four adolescents with persistent blood pressure elevation (greater than 95th%) on placebo
